Frequency domain fluorescence lifetime imaging microscopy (FLIM) has been used in combination with laser scanning confocal microscopy to study the cellular uptake behavior of the antitumor drug doxorubicin (DOX) and micellar-encapsulated DOX (PLyAd-DOX). The endocytosis uptake process of PLyAd-DOX was monitored over 72 hours using confocal microscopy, with a maximum fluorescence recorded at incubation periods around 24 hours. The micellar structure was not found to release the encapsulated DOX during the time course of imaging. FLIM revealed single lifetime distributions of PLyAd-DOX during accumulation in the cytoplasm. The free DOX in contrast was observed both in the cytoplasm and the nuclear domain of the cell, showing bimodal lifetime distributions. There was a marked dependence of the measured free-DOX lifetime on concentration within the cell, in contrast to reference experiments in aqueous solution, where no such dependence was found. The results suggest the formation of macromolecular structures inside the living cells. © 2008 Elsevier Inc. All rights reserved. 
Background
Polymer systems are increasingly being recognized for their potential as delivery devices for existing drugs to improve their therapeutic efficacy. Drugs can be loaded by chemical conjugation or physical encapsulation, and the resulting nano-scale macromolecular prodrugs have demonstrated a number of advantages over small molecular weight drugs, notably prolonged plasma half-lives, selective accumulation in tumours and sustained drug release over extended periods [1] [2] [3] [4] [5] [6] [7] [8] . Functionality of these prodrugs can be finely tuned because of the inherent versatility in polymer chemistry. Much effort has been focused on the development of novel amphiphilic polymers, exhibiting a finely tuned balance of hydrophilicity and hydrophobicity. Such systems tend to self assemble into nanostructures with hydrophobic cores and hydrophilic shells, systems that are particularly promising for the delivery of hydrophobic anti-tumour agents in cancer chemotherapy [9] [10] [11] .
A challenge in the design of macromolecular prodrugs is to ensure an efficient intracellular release of the carried drugs, which is a key requirement for their therapeutic efficacy. Unlike small molecular drugs, macromolecular prodrugs generally enter cells via endocytosis, and they are compartmentalised in the endosome and lysosome. An understanding of their intracellular fate after uptake is important in providing guidance for the design of efficient drug delivery systems. Key to this is the ability to differentiate between conjugated or encapsulated forms of drug and the free released drug inside living cells. Many anticancer drugs are intrinsically fluorescent, e.g. doxorubicin (DOX), which makes them convenient for probing and visualising their location with various microscopic imaging technologies. However, conventional intensity based microscopic techniques are of limited value in this respect because the intensity or spectral response does not differ significantly between polymeric and free drug systems, thus makes the differentiation inside the cells difficult. In this paper we demonstrate the potential of fluorescence imaging microscopy (FLIM) as a tool to successfully distinguish between polymer mediated and free drug inside living cells. Fluorescence lifetime is a sensitive tool to study the local physicochemical environment of a fluorophore. It probes the average time a molecule stays in its excited state before returning to the ground state, yielding information on intramolecular interactions, such as protein binding events [12, 13] , changes in pH [14] , local viscosities [15] , the presence of quenchers such as oxygen or ions [16, 17] , and many other parameters. FLIM is thus able to provide information on drug delivery candidates that other techniques cannot. To the best of our knowledge, the use of FLIM has not been reported in the literature in the specific context of drug delivery research. Partly this is due to the fact that traditional implementations of FLIM, such as time correlated single photon counting (TCSPC) and time gated detection, require the use of expensive laser and detector equipment. Equally importantly, these techniques require high photon fluxes, with associated increases in signal acquisition times, thus reducing their ability to track dynamic changes.
In this paper we demonstrate what we believe to be the first application of FLIM in polymer mediated drug delivery research. In particular we have set up a frequency domain widefield FLIM system, which makes use of inexpensive light emitting diodes (LEDs) as excitation sources. The system is photon efficient and because lifetime information is tracked for all image pixels in parallel, measurements have good temporal resolution, making the technique suitable for dynamic studies in live cell systems. The system operates using an LED, the amplitude of which is modulated at a frequency of 40 MHz. Lifetimes are obtained using a homodyne detection scheme and extracting phase shift and demodulation information of the emitted fluorescent intensity from each individual image pixel. The technique is simple to implement and makes use of high brightness, large emission area LEDs. Their spectral and illumination properties make them ideally suited for widefield FLIM to provide reliable lifetime information at subsecond data acquisition speed, which makes the technique ideally suited for the dynamic imaging over extended observation periods.
The drug carrier studied in the present work was a grafted pseudopeptide, poly(L-lysine adipylamide) with poly (ethylene glycol) side chains (PLA) (Fig. 1 ). This amphiphilic synthetic polymer self assembles into a core-shell like superamolecular structure with DOX encapsulated in its core. Here we present the first example of using LED based frequency domain FLIM (FD-FLIM) in the study of intracellular dynamics of free DOX and of polymeric micellar encapsulated DOX (PLA-DOX).
Methods

Materials
Doxorubicin hydrochloride (DOX.HCl) was obtained from Fluka. Poly (L-lysine adipaminde), prepared from an interfacial polymerization [18] , was treated in dimethyl sulfoxide (DMSO) with methoxypoly(oxyethylene) amine (M n =4400 g mol -1 , 0.05 molar equivalent of [COOH] ), in the presence of N,N'-dicyclohexylcarbodiimide and 4-dimethylaminopyridine. The product was purified by diafiltration (Millipore, MWCO 5000Da) against four volumes of deionized water, before lyophilisation to fine white powder.
The structure of PLA was confirmed by 1 H NMR in d 6 -DMSO.
25 mg of PLA and 5 mg of DOX.HCl were dissolved in dimethyl sulfoxide (12.5 mL) in the presence of triethyl amine (100 μL). An equal volume of deionized water was added and the mixture stirred at room temperature for 1 h, dialyzed (MWCO 12000 Da) against deionized water for 72 h to remove the dimethyl sulfoxide (DMSO), triethyl amine and free DOX, before lyophilization to a red powder occurred.
Determination of drug loading
1 mg of PLA-DOX was dissolved in 1 mL of DMSO, and its absorption at 485 nm was measured on a Shimadzu UV-160A spectrophotometer. The amount of DOX in PLA-DOX was quantified to be 5.1 wt%, based on a standard curve of DOX.HCl.
Steady state fluorescence spectroscopy
The fluorescence spectra of free DOX and PLA-DOX in aqueous solutions were collected using a SPEX FluoroMax-3 spectrofluorometer (HORIBA JOBIN YVON, UK).
Cell culture and sample preparation
Human cervical carcinoma (Hela) cells were grown in Dulbecco's modified Eagle's medium (DMEM, GIBCO) supplemented with 10 % fetal bovine serum (FBS, GIBCO).
Cells were maintained in a humid incubator at 37 o C and with 5 % CO 2. For living cell fluorescence microscopy, cells were seeded into sterilized glass-bottom dishes (Mat Tek, Ashland, MA) a day in advance.
Time Correlated Single Photon Counting
Time correlated single photon counting (TCSPC) measurement was performed at the Department of Physics, Politecnico di Milano, Italy. Free doxorubicin at a concentration of 0.01 mg mL -1 in aqueous solution in standard 10-mm quartz cuvettes was measured.
Picosecond light pulses at 535-545 nm were selected using an optical bandpass filter from a supercontinuum pulse-train generated by a self-mode-locked Ti:sapphire laser and a photonic crystal fibre [19] . 
Laser Scanning Confocal Microscopy
Laser scanning confocal microscopy (Olympus FV300) was used to study the dynamics of PLA-DOX uptake by the Hela cells using a conventional intensity based approach. For this purpose cells were kept on a heater stage at 37 o C and imaged with a 60 × oil immersion objective (1.35 NA Olympus). The 488 nm line from an argon ion laser was used for excitation, and emission was collected between 565 and 630 nm. Cells were incubated with 0.1 mg mL -1 PLA-DOX in a glass-bottom dish and imaged using 488 nm excitation light. The fluorescence emission from PLA-DOX was collected between 565 and 630 nm using the laser scanning confocal microscope after incubation periods of 4, 12, 24, 48, and 72 hours (Fig. 4) , respectively. Fluorescence yields were obtained by normalizing integrated fluorescence intensities to the cellular area (indicated by transmission microscopy). The data were used to quantify the cellular uptake of PLA-DOX as a function of time. It is evident from the images shown in Fig. 4 how PLA-DOX gradually accumulated in the cytoplasm without evidence of entering into the nucleus from which no signals were obtained. The fluorescence yield seemed to increase with time, reaching a maximum after about 24 hours of incubation, followed by a gradual decrease (Fig. 4K ). to (F) show data of free DOX, and series (G) to (I) show the data of PLA-DOX. It is seen that the free DOX is translocated into the nucleus whereas PLA-DOX is not.
Free DOX displayed very strong nuclear accumulation after 24 hours of incubation (Fig.   5A, D) . It is clearly seen in the lifetime images (Fig. 5B, E) that there exist lifetime differences between the nuclear domains and the cytoplasm. These bimodal distributions are clearly exhibited also on the lifetime histograms (Fig. 5C, F) , which show significant shifts towards longer lifetimes in the nucleus compared to the cytoplasm. For example, cells incubated with 0.01 mg mL -1 doxorubicin displayed lifetimes of 1.8 ns in the cytoplasm compared to 3.5 ns in the nucleus (Fig. 5B, C) . At higher incubation concentrations (0.05 mg mL -1 ), the lifetimes were measured to be 1.8 ns in the cytoplasm and 2.8 ns in the nucleus, respectively (Fig. 5E, F) .
The concentration of PLA-DOX was adjusted to yield a DOX concentration of 0.05 mg mL -1 . The PLA micellar prodrug reduced the cytotoxicity of the drugs, and cellular viability was found to be much higher than the cells incubated with 0.05 mg mL -1 free DOX. It appears from Fig. 5G that PLA-DOX is taken up by endocytosis and subsequently localized in small vesicles inside the cytoplasm. Similar to what had been observed using confocal microscopy ( Fig. 4) , no significant accumulation was found of PLA-DOX in the nucleus and thus no doxorubicin signal was detected from the nucleus after 24 hours of incubation (Fig.   5G ). Cytoplasmic PLA-DOX exhibited a single lifetime distribution peaking at around 3.3 ns (Fig. 5H, I ).
As control measurements, fluorescence lifetimes were measured in vitro in solutions containing free DOX and double-stranded DNA. Measurements were performed at a range of (DNA:DOX) ratios. For a fixed amount of DOX solution, the concentration of doublestranded DNA added to the solution was gradually increased. The results are shown in Fig. 6 , and clearly an increase of the DOX lifetime is seen as the (DNA:DOX) ratio is increased, increasing from 1.1 ns to 2.4 ns at the highest (DNA:DOX) ratio.
Discussion
Doxorubicin is an anthracycline antibiotic that is commonly used in the treatment of a wide spectrum of cancers. The exact mechanism of its anti-tumour activity still remains unclear. It is known however that doxorubicin intercalates into DNA, which results in the blocking of topo-isomerase II activity preventing DNA replication and cell division [22] [23] [24] . 1 ns) . The increased lifetime of nuclear DOX compared to cytoplasmic DOX can be ascribed to the known nuclear intercalation effect of DOX with DNA [25, 26] . DOX forms π-π stacks with the aromatic groups of the DNA base pairs, locally reducing the exposure of DOX to external quenchers (i.e. dissolved oxygen), and this leads to the observed increases in fluorescence lifetime.
Lifetime imaging thus has the power to inform directly on the molecular interactions taking place in complex live cell systems, and this underlines its potential for use in drug delivery assays.
Increasing the concentration of free DOX leads to decreased lifetimes (Fig. 5C, F These mechanisms were elucidated further by in vitro lifetime measurements conducted in solutions containing free DOX and DNA at different ratios. Whereas free DOX showed concentration independent lifetime of 1.1 ns in aqueous solution, increases in DOX lifetime were observed on mixing with DNA. This increase is clearly a result of DNA intercalation [25, 26] , resulting in an effective shielding of DOX from external quenchers such as oxygen.
The in vitro observations provide foundation for our in vivo observations, explaining both the increasing lifetimes with intercalation and decreasing lifetimes on high drug loading in the nucleus due to increasing self-quenching.
In conclusion, we demonstrate here the use of frequency domain fluorescence lifetime imaging for the study of drug delivery systems in living cells. 
